The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
  • Login
  • Register
  • Login
  • Register
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
  • 1

    Kim Min-gyu, Go Bo-gyeol bid farewell to 'The Heavenly Idol'

  • 3

    Han Suk-kyu on return of 'Dr. Romantic' with Season 3

  • 5

    Genesis launches 2023 G90 sedan

  • 7

    Churches, Seoul gov't unite to fight low birthrate

  • 9

    Burnout: Cardiothoracic surgery residents work 102 hours a week

  • 11

    Kakao Entertainment, Colombia Record team up for IVE's North American debut

  • 13

    What's next for Do Kwon?

  • 15

    BTS' Jimin releases solo album

  • 17

    Crypto founder Do Kwon is indicted in US, following Montenegro arrest

  • 19

    Over 70% of firms unwilling to embrace longer workweek

  • 2

    Zoo shares sad story of what caused Sero the zebra to escape

  • 4

    Kim Nam-gil to embark on Asia fan-meeting tour

  • 6

    N. Korea tests 'underwater nuclear attack drone,' cruise missiles for nuclear warhead: KCNA

  • 8

    North Korea will pay price for reckless provocations, warns Yoon

  • 10

    Hybe to sell SM shares to Kakao following failed takeover bid

  • 12

    Kyochon heralds 30,000 won fried chicken era

  • 14

    Second daughter of Daesang chairman promoted to vice president

  • 16

    More companies adopt electronic voting amid increase in shareholder activism

  • 18

    Samsung Electronics chief to attend China Development Forum

  • 20

    Samsung Display strike looms due to deadlocked wage negotiations

Close scrollclosebutton

Close for 24 hours

Open
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
Business
  • Tech
  • Bio
  • Companies
Sun, March 26, 2023 | 04:40
Companies
SK Inc. to hold SK Bio Night to seek new opportunities in US
Posted : 2023-01-10 16:58
Updated : 2023-01-11 11:46
Kim Hyun-bin
Print PreviewPrint Preview
Font Size UpFont Size Up
Font Size DownFont Size Down
  • facebook
  • twitter
  • kakaolink
  • whatsapp
  • reddit
  • mailto
  • link
SK Bioscience's vaccine factory, Andong L House, in North Gyeongsang Province / Courtesy of SK Bioscience
SK Bioscience's vaccine factory, Andong L House, in North Gyeongsang Province / Courtesy of SK Bioscience

By Kim Hyun-bin

SK Inc. and its affiliates including SK biopharmaceuticals and SK pharmteco will hold a networking event to expand their partnerships in the U.S., the world's largest bio and pharmaceutical market.

SK Inc. announced that it will hold its SK Bio Night event on Jan. 11 at the Four Seasons Hotel in San Francisco. The meeting will be attended by 100 executives from over 50 companies including SK's global partners and investment companies. The goal of the event is to build a strong understanding of SK's current priorities and discover new opportunities in the U.S. market.

Newly appointed executives from SK Inc. and its affiliates are scheduled to attend the event including SK Inc. CEO and Vice Chairman Jang Dong-hyun, SK pharmteco CEO Joerg Ahlgrimm, SK biopharmaceuticals CEO Lee Dong-hoon and SK Bio Investment Center head Kim Yeon-tae.

They are expected to emphasize their respective companies' bio strengths and seek collaborations in the global biopharmaceutical sector by strengthening relations with investors and partners.

SK pharmteco has been bolstering its competitiveness in the cell and gene therapy (CGT) sector, an emerging growth market in the contract development and manufacturing organization (CDMO) business. Its CEO Joerg Ahlgrimm will unveil the company's business strategy as a global CDMO, along with its vision and competitiveness, to investors and partners at the event.
SK Bioscience's vaccine factory, Andong L House, in North Gyeongsang Province / Courtesy of SK Bioscience
Kim Yeon-tae, head of SK Bio Investment Center

Since entering the biopharmaceutical business, SK Inc. has been achieving impressive results in enhancing its competitiveness by adopting a robust localization strategy that focused on the development of new small-molecule drugs and the CGT CDMO business in the U.S. and Europe.

By consummating large cross-border transactions that include SK's acquisition of a plant in Ireland owned by Bristol Myers Squibb in 2017 (currently SK biotek Ireland) and of AMPAC Fine Chemicals of the U.S. in 2018, SK Inc. was able to scale up its biopharmaceutical business and secure strategically important production bases in the U.S. and Europe.

Through SK Bio Night, SK Inc. plans to explore various business partnerships and investment opportunities in the global market, including the U.S.

"SK strongly believes that establishing long-term partnerships is integral to realizing the company's mission and vision. We wish to engage and create a strong connection with our existing as well as potential future partners by hosting SK Bio Night, with the goal of forging landmark opportunities in key markets such as the U.S. and Europe," said Kim Yeon-tae, head of SK Bio Investment Center. "We are excited to share our impressive growth trajectory with our global partners and investors."


Emailhyunbin@koreatimes.co.kr Article ListMore articles by this reporter
 
Top 10 Stories
1Zoo shares sad story of what caused Sero the zebra to escape Zoo shares sad story of what caused Sero the zebra to escape
2Genesis launches 2023 G90 sedan Genesis launches 2023 G90 sedan
3Churches, Seoul gov't unite to fight low birthrate Churches, Seoul gov't unite to fight low birthrate
4North Korea will pay price for reckless provocations, warns Yoon North Korea will pay price for reckless provocations, warns Yoon
5Burnout: Cardiothoracic surgery residents work 102 hours a week Burnout: Cardiothoracic surgery residents work 102 hours a week
6Kyochon heralds 30,000 won fried chicken era Kyochon heralds 30,000 won fried chicken era
7What's next for Do Kwon? What's next for Do Kwon?
8Second daughter of Daesang chairman promoted to vice president Second daughter of Daesang chairman promoted to vice president
9More companies adopt electronic voting amid increase in shareholder activism More companies adopt electronic voting amid increase in shareholder activism
10Over 70% of firms unwilling to embrace longer workweek Over 70% of firms unwilling to embrace longer workweek
Top 5 Entertainment News
1Kim Min-gyu, Go Bo-gyeol bid farewell to 'The Heavenly Idol' Kim Min-gyu, Go Bo-gyeol bid farewell to 'The Heavenly Idol'
2Yoo Yeon-seok threatens to sue people spreading accusations about him Yoo Yeon-seok threatens to sue people spreading accusations about him
3Han Suk-kyu on return of 'Dr. Romantic' with Season 3 Han Suk-kyu on return of 'Dr. Romantic' with Season 3
4Kim Nam-gil to embark on Asia fan-meeting tour Kim Nam-gil to embark on Asia fan-meeting tour
5Lee Som, Ahn Jae-hong to play married couple in Tving's new series Lee Som, Ahn Jae-hong to play married couple in Tving's new series
DARKROOM
  • Turkey-Syria earthquake

    Turkey-Syria earthquake

  • Nepal plane crash

    Nepal plane crash

  • Brazil capital uprising

    Brazil capital uprising

  • Happy New Year 2023

    Happy New Year 2023

  • World Cup 2022 Final - Argentina vs France

    World Cup 2022 Final - Argentina vs France

CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Contact Us
  • Products & Services
  • Subscribe
  • E-paper
  • RSS Service
  • Content Sales
  • Site Map
  • Policy
  • Code of Ethics
  • Ombudsman
  • Privacy Statement
  • Terms of Service
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group